Working together to create breakthroughs for people with progressive MS

A first-of-its-kind global research network funded by the International Progressive MS Alliance is aimed at developing new, effective treatments for progressive MS. Join Professor Francisco Quintana from Harvard’s Brigham and Women’s Hospital as he discusses how a team of researchers from multiple countries are working together to create breakthroughs to improve the lives of people with progressive MS in this global webcast.

The team of researchers from the United States, Canada, Israel and the pharmaceutical company, Sanofi Genzyme are focusing on the innate immune system. While the innate immune system normally functions to protect the body from infection, Dr. Quintana and others have found that some innate immune cells in the nervous system promote disease activity in MS. The team has identified several compounds that have the potential to slow or stop MS from progressing.

In addition to this work, the team recently discovered a subset of brain cells that fights MS inflammation with instructions from gut bacteria. These findings could enable new therapeutic approaches to combat MS such as customized probiotics that could turn on this anti-inflammatory activity.

Join us for the global webcast on 4 March

A global webcast on 4 March will be live-streamed from the MS International Federation Facebook page and YouTube channel. Dr. Quintana will share work he and his team are accomplishing to accelerate life-changing treatments for people with progressive MS and answer questions submitted via the registration form below.

Webcast start time :  08:00 PST / 10:00 CST /  13:00 BRT / 16:00 GMT / 18:30 EET / 21:30 IST / 03:00 AEDT

Registration will ensure access to the webcast post-event if you are unable to join live.

There is an urgent, worldwide need for life-changing solutions for people affected by progressive MS. The International Progressive MS Alliance is working to answer that need. We are rallying the global community in an unprecedented collaboration of MS organizations, researchers, healthcare professionals, pharmaceutical companies, trusts, foundations, donors and people affected by MS. MSIF is proud to be a founding member of the International Progressive MS Alliance.

Register now